RE-BVS – Piemonte Repository

Sfoglia per AUTORE
GUGLIELMINI P
Collezione AOU Alessandria

Items : 9

A rare and severe lichenoid skin eruption after apalutamide treatment for prostate cancer. in Annales de dermatologie et de venereologie / Ann Dermatol Venereol. 2023 Dec;150(4):310-311. doi: 10.1016/j.annder.2023.09.001. Epub 2023 Oct 29.

2023
AOU Alessandria

Guglielmini PF; Massone C; Grasso C; Francese A; Vincenti M; Chiodi S; Rossi M; Maconi A;

Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study. in ESMO open / ESMO Open. 2022 Apr;7(2):100431. doi: 10.1016/j.esmoop.2022.100431. Epub 2022 Apr 8.

2022
AOU Alessandria
AOU Città della Salute di Torino

Beccaglia P; Schips L; Aglietta M; Nova P; Carella C; Guglielmini PF; Ludovico GM; Gasparro D; Galli L; Airoldi M; De Placido S; Rossetti S; Cinieri S; Bordonaro R; Maisano R; Alitto AR; Chiuri VE; Giordano M; Procopio G; Sciarra A; Livi L; Santini D;

Is Medication-Related Osteonecrosis of the Jaws (MRONJ) Associated to Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors? A Word of Cautiousness. Comment on Marcianò et al. Medication-Related Osteonecrosis of the Jaws and CDK4/6 Inhibitors: A Recent Association. Int. J. Environ. Res. Public Health 2020, 17, 9509. in International journal of environmental research and public health / Int J Environ Res Public Health. 2021 Sep 27;18(19):10143. doi: 10.3390/ijerph181910143.

2021
ASL Cuneo 2
AOU Alessandria

Rossi M; Fasciolo A; Vincenti M; Guglielmini PF; Alessio M; Fusco V;

Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-naïve mCRPC patients after ADT failure: A prospective analysis of the italian real-world study ABITUDE. in Journal of bone oncology / J Bone Oncol. 2020 Dec 2;26:100341. doi: 10.1016/j.jbo.2020.100341. eCollection 2021 Feb.

2021
AOU Alessandria

Panebianco F; Carlini P; Sartori D; Lanzetta G; Mencoboni M; Acquati M; Fagnani D; Ceresoli GL; D'Angelillo RM; Chiuri VE; Guglielmini PF; Bordonaro R; Gasparro D; Cinieri S; Santini D; Beccaglia P; Procopio G;

Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2021 Dec;70(12):3679-3692. doi: 10.1007/s00262-021-03024-0. Epub 2021 Aug

2021
AOU Alessandria
AOU San Luigi di Orbassano

Altosole T; Ferrera F; Astone G; Kalli F; Parodi A; Scagliotti G; Signori A; Guglielmini P; Morales-Barrera R; Carles J; Del Conte G; Aglietta M; Tomasello L; Zanardi E; Nolè F; Fenoglio D; Filaci G; Lamperti G; Criscuolo D; Gianese F; Boccardo F;

Incidence and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with metastatic castration-resistant prostate cancer. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 Nov;140:140-146. doi: 10.1016/j.ejca.2020.09.018. Epub 2020 Oct 20.

2020
AOU Alessandria

Caffo O; Gasparro D; Di Lorenzo G; Volta AD; Guglielmini P; Zucali P; Bortolus R; Cavo A; Ceresoli G; Chiari R; Fornarini G; Fratino L; Iaculli A; Maruzzo M; Masini C; Morelli F; Mucciarini C; Procopio G; Sabbatini R; Verri E; Kinspergher S; Maines F; Messina C; Veccia A; Donini M;

Prognostic role of early PSA drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide. in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2020 Dec;72(6):737-745. doi: 10.23736/S0393-2249.20.03708-X. Epub 2020 Apr 10.

2020
AOU Alessandria
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Numico G; Scagliotti GV; Guglielmini P; Lacidogna G; Turco F; Pisano C; Vignani F; Di Stefano RF; Tucci M; Sonetto C; Buttigliero C;

Effectiveness of abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer in a large prospective real-world cohort: the ABItude study. in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2020 Oct 29;12:1758835920968725. doi: 10.1177/1758835920968725. eCollection 2020

2020
AOU Alessandria
AOU Città della Salute di Torino

Sciarra A; Livi L; Beccaglia P; Schips L; Aglietta M; Naglieri E; Fagnani D; Guglielmini P; Ludovico GM; Gasparro D; Airoldi M; Sbrana A; De Placido S; Facchini G; Bordonaro R; Calvani N; Maisano R; Mantini G; Giordano M; Chiuri VE; Procopio G; Santini D;

Chemotherapy-Induced Neutropenia and Outcome in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With First-Line Docetaxel. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2018 Aug;16(4):318-324. doi: 10.1016/j.clgc.2018.05.006. Epub 2018 Jun 1.

2018
AOU Alessandria
AO Ordine Mauriziano

Scagliotti GV; Guglielmini P; Numico G; Lacidogna G; Pignataro D; Zichi C; Leone G; Di Stefano RF; Vignani F; Tucci M; Buttigliero C; Di Maio M;